[go: up one dir, main page]

NO20065701L - Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin - Google Patents

Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin

Info

Publication number
NO20065701L
NO20065701L NO20065701A NO20065701A NO20065701L NO 20065701 L NO20065701 L NO 20065701L NO 20065701 A NO20065701 A NO 20065701A NO 20065701 A NO20065701 A NO 20065701A NO 20065701 L NO20065701 L NO 20065701L
Authority
NO
Norway
Prior art keywords
oromucosal
agomelatine
pharmaceutical composition
sublingual administration
orodispersible pharmaceutical
Prior art date
Application number
NO20065701A
Other languages
English (en)
Inventor
Patrick Wuthrich
Marc Julien
Francois Tharrault
Jean-Manuel Pean
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36663148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065701(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20065701L publication Critical patent/NO20065701L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører en belagt fast orodispersibel farmasøytisk sammensetning for administrasjonen av agomelatin ved den orale, oromukosale eller sublingvale rute.
NO20065701A 2005-12-14 2006-12-11 Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin NO20065701L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0512647A FR2894475B1 (fr) 2005-12-14 2005-12-14 Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine

Publications (1)

Publication Number Publication Date
NO20065701L true NO20065701L (no) 2007-06-15

Family

ID=36663148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065701A NO20065701L (no) 2005-12-14 2006-12-11 Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin

Country Status (40)

Country Link
US (1) US7892575B2 (no)
EP (1) EP1800669B1 (no)
JP (2) JP4996225B2 (no)
KR (3) KR20070063420A (no)
CN (2) CN101919800A (no)
AP (1) AP2714A (no)
AR (1) AR058332A1 (no)
AT (1) ATE474561T1 (no)
AU (1) AU2006252051B2 (no)
BR (1) BRPI0605214A (no)
CA (1) CA2571202C (no)
CO (1) CO5770094A1 (no)
CR (1) CR8788A (no)
CU (1) CU23603B7 (no)
CY (1) CY1110824T1 (no)
DE (1) DE602006015592D1 (no)
DK (1) DK1800669T3 (no)
EA (1) EA013751B1 (no)
ES (1) ES2348994T3 (no)
FR (1) FR2894475B1 (no)
GE (1) GEP20084509B (no)
GT (1) GT200600500A (no)
HN (1) HN2008000874A (no)
HR (1) HRP20100517T1 (no)
IL (1) IL180036A0 (no)
MA (1) MA28722B1 (no)
MX (1) MXPA06014605A (no)
MY (1) MY143221A (no)
NO (1) NO20065701L (no)
NZ (1) NZ552025A (no)
PE (1) PE20071030A1 (no)
PL (1) PL1800669T3 (no)
PT (1) PT1800669E (no)
RS (1) RS51452B (no)
SG (1) SG133531A1 (no)
SI (1) SI1800669T1 (no)
TW (1) TWI327911B (no)
UA (1) UA86622C2 (no)
WO (1) WO2007068829A1 (no)
ZA (1) ZA200610511B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008801A2 (en) * 2006-07-11 2008-01-17 Mcneil Nutritionals, Llc Solid oral dosage vitamin and mineral compositions
SI2238974T1 (sl) 2009-04-09 2013-09-30 E-Pharma Trento S.P.A. Granulat za formuliranje orodisperzibilnih tablet
CN101781226B (zh) * 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
EA201391053A1 (ru) * 2011-01-17 2013-12-30 Такеда Фармасьютикал Компани Лимитед Таблетка, диспергируемая в ротовой полости
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2013054582A1 (en) 2011-10-14 2013-04-18 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
PL2810656T3 (pl) * 2013-06-06 2018-01-31 Zentiva Ks Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
CN115671064A (zh) * 2014-02-07 2023-02-03 讯唐制药公司 全天然无毒舌下药物递送系统
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法
EP4076380B1 (en) * 2019-12-20 2024-04-24 LTS Lohmann Therapie-Systeme AG Transmucosal therapeutic system containing agomelatine
ES3003263T3 (en) * 2019-12-20 2025-03-10 Lts Lohmann Therapie Systeme Ag Transmucosal therapeutic system containing agomelatine
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
JP2002338500A (ja) * 2001-03-15 2002-11-27 Yamanouchi Pharmaceut Co Ltd 苦味を低減した口腔内速崩壊錠および苦み低減化方法
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
UA86622C2 (ru) 2009-05-12
US20070134331A1 (en) 2007-06-14
EP1800669A1 (fr) 2007-06-27
PL1800669T3 (pl) 2010-12-31
MXPA06014605A (es) 2009-02-11
CA2571202C (fr) 2012-01-10
FR2894475B1 (fr) 2008-05-16
CA2571202A1 (fr) 2007-06-14
KR20080108068A (ko) 2008-12-11
CU23603B7 (es) 2010-12-08
DE602006015592D1 (de) 2010-09-02
SG133531A1 (en) 2007-07-30
KR101013667B1 (ko) 2011-02-10
SI1800669T1 (sl) 2010-11-30
EA200602104A1 (ru) 2007-06-29
CN1981752A (zh) 2007-06-20
ES2348994T3 (es) 2010-12-21
US7892575B2 (en) 2011-02-22
WO2007068829A1 (fr) 2007-06-21
PE20071030A1 (es) 2007-11-17
NZ552025A (en) 2008-12-24
MY143221A (en) 2011-03-31
DK1800669T3 (da) 2010-10-25
MA28722B1 (fr) 2007-07-02
AU2006252051A1 (en) 2007-06-28
CN101919800A (zh) 2010-12-22
AP2006003844A0 (en) 2006-12-31
JP2012092132A (ja) 2012-05-17
HRP20100517T1 (hr) 2010-10-31
PT1800669E (pt) 2010-08-17
AP2714A (en) 2013-07-31
CR8788A (es) 2008-08-21
AR058332A1 (es) 2008-01-30
CO5770094A1 (es) 2007-06-29
AU2006252051B2 (en) 2013-03-14
CY1110824T1 (el) 2015-06-10
TWI327911B (en) 2010-08-01
RS51452B (sr) 2011-04-30
TW200738230A (en) 2007-10-16
KR20100012858A (ko) 2010-02-08
CU20060243A7 (es) 2009-09-08
IL180036A0 (en) 2008-01-20
KR20070063420A (ko) 2007-06-19
GT200600500A (es) 2007-07-25
HN2008000874A (es) 2012-02-27
JP4996225B2 (ja) 2012-08-08
EA013751B1 (ru) 2010-06-30
GEP20084509B (en) 2008-10-10
EP1800669B1 (fr) 2010-07-21
CN1981752B (zh) 2011-11-02
ATE474561T1 (de) 2010-08-15
ZA200610511B (en) 2008-05-28
FR2894475A1 (fr) 2007-06-15
HK1101802A1 (en) 2007-10-26
BRPI0605214A (pt) 2007-10-09
JP2007182440A (ja) 2007-07-19

Similar Documents

Publication Publication Date Title
NO20065701L (no) Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
EA200802444A1 (ru) Стабилизированные фармацевтические композиции, содержащие фезотеродин
NO20043367L (no) Oralt farmasoytisk preparat
DK3219705T3 (da) Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
NO20080991L (no) Bazedoksifen acetat formuleringer
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
CL2007001919A1 (es) Compuestos derivados de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-3-onas; composicion farmaceutica que comprende a dichos compuestos, utiles como anticonceptivos.
CL2007002812A1 (es) Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih.
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
NO20064808L (no) Orale matrixformuleringer med licarbazepin
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
CY1112501T1 (el) Φαρμακευτικες συνθεσεις περιεχουσες λεφλουνομιδη
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
ECSP088574A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
IT1356828B (it) Composizione, particolarmente per la preparazione di malte cementizie.
CL2008003918A1 (es) Compuesto derivado de gama-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, dispositivo intrauterino que lo contiene y su uso para la contracepcion oral y para trastornos pre, peri y postmenopausicos.
FR2907121B1 (fr) Nouveaux derives morphiniques
BRPI0508279A (pt) composições de peróxido estabilizadas
TNSN06396A1 (fr) Compositions pharmaceutiques orodispersible pour administration oromucosale ou sublinguale d'agomelatine
ITRM20060710A1 (it) Dispositivo di supporto per la correzione dell'ipercifosi.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application